Nodular Basal Cell Carcinoma Clinical Trial
Official title:
Bi-center, Open Label, Non-comparative Trial Exploring Efficacy and Safety of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma (nBCC)
The primary objective is the observation and description of the preliminary efficacy of resiquimod gel 0.06% on a single nodular basal cell carcinoma (nBCC) in a small group of patients.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04552990 -
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02270645 -
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
|
N/A | |
Completed |
NCT02018679 -
Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma
|
Phase 1 | |
Recruiting |
NCT05157763 -
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02242929 -
Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
|
Phase 3 | |
Recruiting |
NCT04744935 -
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
|
N/A | |
Completed |
NCT04470726 -
Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
|
Phase 1/Phase 2 |